Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CYP51A1 | Q16850 | 3/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.35 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.35 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.34 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.34 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.34 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23854165 | 0.81 | CA1 (0.47) | CA1CA2CA9CA5ACA5B | |
| SCHEMBL13882617 | 0.81 | CA1 (0.47) | CA1CA2CA9CA5ACA5B | |
| SCHEMBL16748959 | 0.80 | CA1 (0.58) | CA1CA2CA9CA5ACA5B | |
| SCHEMBL20954188 | 0.78 | CYP51A1 (0.43) | CA1CA2CA9CA5ACA5B | |
| SCHEMBL13475881 | 0.77 | CA1 (0.48) | ALDH1A1CA1CA2CA9CA5A | |
| SCHEMBL19714967 | 0.77 | CA1 (0.44) | CA1CA2CA9CA5ACA5B | |
| SCHEMBL30002551 | 0.76 | CA1 (0.52) | ALDH1A1CA1CA2CA9CA5A | |
| SCHEMBL28837942 | 0.76 | CA1 (0.42) | CA1CA2CA9CA5ACA5B | |
| SCHEMBL17870933 | 0.75 | TP53 (0.44) | ALDH1A1CA1CA2CA9CA5A | |
| SCHEMBL20954189 | 0.75 | KMT2A (0.48) | ALDH1A1CA1CA2CA9TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1990541-B | Crosslinkable compositions, process for their preparation and their use | LANXESS DEUTSCHLAND GMBH | 2012-06-20 | — | — | CN | claimed |
| CN-1990541-A | Crosslinkable compositions, process for their preparation and their use | LANXESS DEUTSCHLAND GMBH (DE) | 2007-07-04 | — | — | CN | claimed |
| EP-4519385-A2 | BIOLUMINESCENCE-TRIGGERED PHOTOCATALYTIC LABELING | PROMEGA CORPORATION (US) | 2025-03-12 | — | — | EP | disclosed |
| US-20240191211-A1 | BIOLUMINESCENCE-TRIGGERED PHOTOCATALYTIC LABELING | PROMEGA CORPORATION | 2024-06-13 | — | — | US | disclosed |
| WO-2023215514-A2 | BIOLUMINESCENCE-TRIGGERED PHOTOCATALYTIC LABELING | PROMEGA CORPORATION (US) | 2023-11-09 | — | — | WO | disclosed |
| CN-113582993-B | Condensed polycyclic compound containing triazahydronaphthalene structure and preparation method and application thereof | 广州大学 | 2022-04-19 | — | — | CN | disclosed |
| US-20140114086-A1 | Clinprost, Isocarbacyclin And Analogs Thereof And Methods Of Making The Same | THE UNIVERSITY OF NORTH CAROLINA AT GREENSBORO | 2014-04-24 | — | — | US | disclosed |
| US-20140114086-A1 | Clinprost, Isocarbacyclin And Analogs Thereof And Methods Of Making The Same | THE UNIVERSITY OF NORTH CAROLINA AT GREENSBORO | 2014-04-24 | — | — | US | disclosed |
| CN-1990541-B | Crosslinkable compositions, process for their preparation and their use | LANXESS DEUTSCHLAND GMBH | 2012-06-20 | — | — | CN | disclosed |
| EP-1865012-A1 | PHOTOSENSITIVE RESIN, PHOTOSENSITIVE COMPOSITION AND PHOTOCROSSLINKED ITEM | Toyo Gosei Kogyo Co., Ltd. (JP) | 2007-12-12 | — | — | EP | disclosed |
| WO-2007136638-A2 | PROSTAGLANDIN TRANSPORTER INHIBITORS | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 2007-11-29 | — | — | WO | disclosed |
| CN-1990541-A | Crosslinkable compositions, process for their preparation and their use | LANXESS DEUTSCHLAND GMBH (DE) | 2007-07-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140114086-A1 | Clinprost, Isocarbacyclin And Analogs Thereof And Methods Of Making The Same | PTGIS, CRH, PTGIR | ALDH1A1 2556/4885CA1 1383/4885CA2 639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.